These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7713956)

  • 41. Compound changes and tooth mineralization effects of glass ionomer cements containing bioactive glass (S53P4), an in vivo study.
    Yli-Urpo H; Närhi M; Närhi T
    Biomaterials; 2005 Oct; 26(30):5934-41. PubMed ID: 15958240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioactive bone cement: the effect of amounts of glass powder and histologic changes with time.
    Tamura J; Kawanabe K; Yamamuro T; Nakamura T; Kokubo T; Yoshihara S; Shibuya T
    J Biomed Mater Res; 1995 May; 29(5):551-9. PubMed ID: 7622540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Demineralizing effect of dental cements on human dentin.
    Shimada Y; Kondo Y; Inokoshi S; Tagami J; Antonucci JM
    Quintessence Int; 1999 Apr; 30(4):267-73. PubMed ID: 10635255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gentamicin release from two-solution and powder-liquid poly(methyl methacrylate)-based bone cements by using novel pH method.
    Merkhan IK; Hasenwinkel JM; Gilbert JL
    J Biomed Mater Res A; 2004 Jun; 69(3):577-83. PubMed ID: 15127405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ion release, porosity, solubility, and bioactivity of MTA Plus tricalcium silicate.
    Gandolfi MG; Siboni F; Primus CM; Prati C
    J Endod; 2014 Oct; 40(10):1632-7. PubMed ID: 25260736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel resorbable glass-ceramic scaffolds for hard tissue engineering: from the parent phosphate glass to its bone-like macroporous derivatives.
    Bretcanu O; Baino F; Verné E; Vitale-Brovarone C
    J Biomater Appl; 2014 May; 28(9):1287-303. PubMed ID: 24080165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioactive silica-based nanomaterials for doxorubicin delivery: evaluation of structural properties associated with release rate.
    Prokopowicz M
    Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):3942-50. PubMed ID: 23910300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium carbonate-calcium phosphate mixed cement compositions for bone reconstruction.
    Combes C; Bareille R; Rey C
    J Biomed Mater Res A; 2006 Nov; 79(2):318-28. PubMed ID: 16817210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a strontium-containing hydroxyapatite bone cement.
    Guo D; Xu K; Zhao X; Han Y
    Biomaterials; 2005 Jul; 26(19):4073-83. PubMed ID: 15664634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a novel aluminum-free glass ionomer cement based on magnesium/strontium-silicate glasses.
    Kim DA; Abo-Mosallam HA; Lee HY; Kim GR; Kim HW; Lee HH
    Mater Sci Eng C Mater Biol Appl; 2014 Sep; 42():665-71. PubMed ID: 25063167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of sodium bicarbonate amount on in vitro indomethacin release from self-setting carbonated-apatite cement.
    Otsuka M; Matsuda Y; Wang Z; Fox JL; Higuchi WI
    Pharm Res; 1997 Apr; 14(4):444-9. PubMed ID: 9144729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlled release of cephalexin through gellan gum beads: effect of formulation parameters on entrapment efficiency, size, and drug release.
    Agnihotri SA; Jawalkar SS; Aminabhavi TM
    Eur J Pharm Biopharm; 2006 Jul; 63(3):249-61. PubMed ID: 16621483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tetracalcium Phosphate/Monetite/Calcium Sulfate Hemihdrate Biocement Powder Mixtures Prepared by the One-Step Synthesis for Preparation of Nanocrystalline Hydroxyapatite Biocement-Properties and In Vitro Evaluation.
    Medvecky L; Giretova M; Stulajterova R; Luptakova L; Sopcak T
    Materials (Basel); 2021 Apr; 14(9):. PubMed ID: 33922310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation and characterization of calcium sulfate-biomimetic apatite nanocomposites for controlled release of antibiotics.
    Hesaraki S; Moztarzadeh F; Nemati R; Nezafati N
    J Biomed Mater Res B Appl Biomater; 2009 Nov; 91(2):651-661. PubMed ID: 19582854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro drug release of antibiotic-loaded porous hydroxyapatite cement.
    Tung IC
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(1):81-8. PubMed ID: 7719447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physicochemical properties of newly developed bioactive glass cement and its effects on various cells.
    Washio A; Nakagawa A; Nishihara T; Maeda H; Kitamura C
    J Biomed Mater Res B Appl Biomater; 2015 Feb; 103(2):373-80. PubMed ID: 24895094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incorporation of a controlled-release glass into a calcium phosphate cement.
    Khairoun I; Boltong MG; Gil FJ; Driessens FC; Planell JA; Seijas MM; Martínez S
    J Mater Sci Mater Med; 1999 Apr; 10(4):215-8. PubMed ID: 15348153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A glass polyalkenoate cement carrier for bone morphogenetic proteins.
    Alhalawani AM; Rodriguez O; Curran DJ; Co R; Kieran S; Arshad S; Keenan TJ; Wren AW; Crasto G; Peel SA; Towler MR
    J Mater Sci Mater Med; 2015 Mar; 26(3):151. PubMed ID: 25773232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Active iron-rich belite sulfoaluminate cements: clinkering and hydration.
    Cuberos AJ; De la Torre AG; Alvarez-Pinazo G; Martín-Sedeño MC; Schollbach K; Pöllmann H; Aranda MA
    Environ Sci Technol; 2010 Sep; 44(17):6855-62. PubMed ID: 20701316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Compression properties of cephalexin powder and physical properties of the tablet.
    Kaneniwa N; Imagawa K; Otsuka M
    Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4986-93. PubMed ID: 6534547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.